Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cytotools strengthens unit DermaTools Biotech GmbH through capital increase

Feb 3 (Reuters) - CytoTools AG  T5OG.DE : 
    * Strengthens subsidiary DermaTools Biotech GmbH through a 
capital increase 
    * DermaTools Biotech GmbH receives about 1 million euro ($1 
million) of fresh capital 
    * Funds to be used to prepare and repeat phase III trial in 
europe for treatment of diabetic foot 
 
Source text for Eikon:  ID:nEQ5HXmsqa  
Further company coverage:  T5OG.DE  
 
($1 = 0.9152 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))

Recent news on bioXXmed AG

See all news